Approval · Notice of Compliance 34683 · 2025
KERENDIA: Notice of Compliance 34683
Issued January 9, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34683
- Date
- January 9, 2025
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a manufacturing site and/or manufacturer involving production of the drug substance
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KERENDIA | Not yet assigned | — |
Medicinal ingredients
- FINERENONE 10 MG per TAB
- FINERENONE 20 MG per TAB